Ballicules.com

Sugammadex

BRIDION

What it isModified gamma-cyclodextrin that encapsulates rocuronium and vecuronium; reversal of neuromuscular blockade.

Why this oneIt reverses even profound blockade within minutes, which neostigmine cannot, and needs no antimuscarinic cover.

What limits itIt binds hormonal contraceptives, so a week of alternative contraception is required. Bradycardia; it does not reverse succinylcholine.

FDA label

FDA dosingPopulationStartTargetMax
Reversal of rocuronium/vecuronium block — deep (1-2 PTC, no TOF twitches)Adults, single IV bolus4 mg/kg4 mg/kg
Reversal of rocuronium/vecuronium block — moderate (2nd TOF twitch reappeared)Adults, single IV bolus2 mg/kg2 mg/kg
Immediate reversal (~3 min after 1.2 mg/kg rocuronium; rocuronium only)Adults, single IV bolus16 mg/kg16 mg/kg

Renal Not recommended in severe renal impairment (CrCl <30 mL/min), including patients on dialysis.

Hepatic Undefined

Waiting time to re-administer an NMBA depends on sugammadex dose and renal function; consider a nonsteroidal NMBA.

Instructions

Cautions

Adverse reactions

Pregnancy Insufficient human data; animal studies showed reduced fetal weight/ossification at high (maternally toxic) doses.

Lactation Undefined

NO BOXED WARNINGS

Principal riskIt binds hormonal contraceptives for a week

Classes and tags

Clinical profile

Direct muscarinic antagonism0 / 4

Mechanism of action: Sugammadex ballicule

Sugammadex ballicule: receptor binding, kinetics and half-life diagram

Open Sugammadex in the interactive console ↗

Memory aids: mascots and interaction avatars

Sugammadex BRIDION mascot mnemonic cartoon
“Mad sugar”
molecular cage” encapsulates the rocuronium molecule within a lipophilic core

Open Sugammadex in the interactive console ↗